MHRA launches public consultation on future of medical device regulation

Launched today by the Medicines and Healthcare products Regulatory Agency (MHRA), the 10-week consultation gives everyone the opportunity to draw on their own experiences and contribute to the improvement of the regulatory framework and therefore patient safety in the future. From hearing aids and walking sticks, to insulin pumps and...

Guardtech geared up for September conference double header

Haverhill firm set to share leading products and services at Cleanroom Technology Conference and Med-Tech Innovation Expo   GUARDTECH CLEANROOMS are all set for the start of their 2021 conference season – with a prestigious double header on the horizon this September. The controlled environment kings and queens are excited...

Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three years. Quotient acquired the Alnwick facility from Arcinova...

EU clinical trials portal to go live in early 2022

It has been a while, but the EU Clinical Trials Information System (CTIS) is set to go live on 31 January 2022. This means that the system set up in 2014 under the Clinical Trials Regulation will finally come into effect. The European Medicines Agency has published a set of training and information resources to assist...

Life Science Group receives ISO 13485 accreditation

Life Science Group (LSG), one of the UK's leading suppliers of life science manufacturing and research solutions, has achieved ISO 13485 accreditation for its manufacture of medical devices from the British Standards Institution (BSI). Jenny Murray, Managing Director, Life Science Group Ltd, said: "We are delighted to be awarded the...

Acquisition to support the next generation of diagnostic technologies

Mills & Reeve has acted for the majority shareholders of Biocrucible, a Cambridge based molecular diagnostics company, on their sale to Sapphiros. Biocrucible is a leading molecular diagnostics company which applies novel isothermal amplification methods to disposable and point-of-care diagnostic technologies, and seeks to enhance the behaviour and kinetics of...

Anglia Ruskin to lead NHS entrepreneurship training

Anglia Ruskin University (ARU) has been chosen as the official partner of NHS England and NHS Improvement to nurture healthcare innovators from across the country and help them gain the commercial skills, knowledge and experience to make their ideas become a reality. The NHS Clinical Entrepreneur Programme was founded in 2016 and...